Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in Primary Molars Affected With Proximal Versus Occlusal Decay
NCT ID: NCT07171229
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
58 participants
INTERVENTIONAL
2025-09-01
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy
NCT07261761
The Influence of Magnification and Clinical Experience on the Outcome of Pulpotomy in Mature Adult Teeth
NCT06231290
Pulp Inflammatory Markers and Outcome of Pulpotomy
NCT06960603
Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.
NCT05464797
Evaluation of Post Operative Pain and Success Rate After Pulpotomy
NCT04933955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Standard clinical protocol for both groups with occlusal and proximal decay:
1. A detailed history of symptoms will be obtained, and a thorough clinical examination will be conducted.
2. Pre-operative pain intensity will be assessed using a validated five-face visual analog scale (VAS), where children select the face that best represents their pain level.
3. A standard pre-operative periapical radiograph will be taken, ensuring the image extends beyond the root tip and shows no distortion or processing errors.
4. Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
5. To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
6. Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s. to obtain pulpal blood samples. The specimens will be collected into heparin-coated tubes with 1 mg saline solution and stored at - 20 °C (-4.0 °F) for 6 months until the day of testing.
7. A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation. Intra-operative assessment of pulp vitality will be conducted, with healthy vital pulp appearing as uniformly reddish-pink vascular tissue and non-vital pulp as dark avascular tissue or yellowish liquefied areas. If necrotic, the tooth will be excluded from the study, and local management protocols will be followed for treatment (Bas et al., 2024).
8. MTA will be used as medicament of choice for pulpotomy.
9. Once a 2-3 mm thickness is ensured, the cavity will be filled with restorative glass ionomer cement to seal it.
10. The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
occlusal decay
Primary molars diagnosed with reversible pulpits caused by occlusal decay
Pulpotomy
* Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
* To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
* Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s.
* A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation
* MTA will be used as medicament of choice for pulpotomy.
* The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.
Measuring Cytokines level
measuring cytokines level as an indicator for pulp inflammation
Proximal decay
Primary molars diagnosed with reversible pulpits caused by Proximal decay.
Pulpotomy
* Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
* To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
* Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s.
* A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation
* MTA will be used as medicament of choice for pulpotomy.
* The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.
Measuring Cytokines level
measuring cytokines level as an indicator for pulp inflammation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulpotomy
* Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
* To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
* Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s.
* A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation
* MTA will be used as medicament of choice for pulpotomy.
* The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.
Measuring Cytokines level
measuring cytokines level as an indicator for pulp inflammation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caries in proximal surface to the dentine full thickness.
* Caries in occlusal surface to the dentine full thickness.
* Radicular pulp health is verified by achieving hemostasis within eight minutes of compression using a cotton pellet with 5% sodium hypochlorite.
Exclusion Criteria
* Primary molars with spontaneous pain.
* Medically compromised patients who have systemic disease.
* Uncooperative children who refuse treatment.
* Children whose parents are unwilling to place stainless steel crowns.
* Children whose parents or caregivers refuse to participate in the study or are unable to attend follow-up visits.
4 Years
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasmin Khalifa
PHD candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hany Saber
Role: STUDY_CHAIR
Professor of Pediatric Dentistry, Faculty of dentistry, Cairo Univeristy
Maii Mohammed
Role: STUDY_DIRECTOR
lecturer of Pediatric Dentistry, Faculty of dentistry, Cairo Univeristy
Yasmin Magdi Khalifa
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo Univeristy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yasmin Magdi Khalifa
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14422023529314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.